Analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a research report issued to clients and investors on Monday. The firm set a "hold" rating on the stock.
Separately, Benchmark restated a "speculative buy" rating and set a $1.25 price objective on shares of Milestone Scientific in a research note on Wednesday, November 20th.
Get Our Latest Stock Report on MLSS
Milestone Scientific Trading Down 8.5 %
Shares of Milestone Scientific stock traded down $0.10 on Monday, reaching $1.08. 197,533 shares of the company were exchanged, compared to its average volume of 442,141. Milestone Scientific has a one year low of $0.54 and a one year high of $1.27. The company has a 50-day moving average of $0.86 and a 200 day moving average of $0.89. The company has a market capitalization of $84.12 million, a price-to-earnings ratio of -15.43 and a beta of 1.10.
Insider Buying and Selling at Milestone Scientific
In other news, Director Leonard Osser sold 107,984 shares of the company's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now owns 4,606,882 shares of the company's stock, valued at approximately $4,284,400.26. This represents a 2.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 24.75% of the company's stock.
Institutional Investors Weigh In On Milestone Scientific
A number of institutional investors have recently modified their holdings of the business. Geode Capital Management LLC raised its stake in Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock worth $480,000 after purchasing an additional 31,572 shares in the last quarter. World Investment Advisors LLC bought a new position in shares of Milestone Scientific during the third quarter worth approximately $91,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific in the third quarter valued at approximately $48,000. Institutional investors own 5.79% of the company's stock.
About Milestone Scientific
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Stories
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
